mef Search Results


95
ATCC mouse stromal fibroblast mef bl
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Mouse Stromal Fibroblast Mef Bl, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse stromal fibroblast mef bl/product/ATCC
Average 95 stars, based on 1 article reviews
mouse stromal fibroblast mef bl - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

91
Proteintech mef 2 isoform a d
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Mef 2 Isoform A D, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef 2 isoform a d/product/Proteintech
Average 91 stars, based on 1 article reviews
mef 2 isoform a d - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology h5 mouse anti mef 2 santa cruz
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
H5 Mouse Anti Mef 2 Santa Cruz, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h5 mouse anti mef 2 santa cruz/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
h5 mouse anti mef 2 santa cruz - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

94
R&D Systems mouse embryonic fibroblast conditioned medium
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Mouse Embryonic Fibroblast Conditioned Medium, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse embryonic fibroblast conditioned medium/product/R&D Systems
Average 94 stars, based on 1 article reviews
mouse embryonic fibroblast conditioned medium - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

93
R&D Systems mouse fibroblast conditioned media mef
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Mouse Fibroblast Conditioned Media Mef, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse fibroblast conditioned media mef/product/R&D Systems
Average 93 stars, based on 1 article reviews
mouse fibroblast conditioned media mef - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

94
Proteintech pyrin
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Pyrin, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pyrin/product/Proteintech
Average 94 stars, based on 1 article reviews
pyrin - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mef2d antibody
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Mef2d Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef2d antibody/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mef2d antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

96
ATCC hpscs sigma aldrich epithelial 1 ipsc0028 h9 hescs wicell wa09 mefs dr4 atcc scrc 1045 c57bl 6 scrc
Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and <t>MEF-BL/6–1</t> cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.
Hpscs Sigma Aldrich Epithelial 1 Ipsc0028 H9 Hescs Wicell Wa09 Mefs Dr4 Atcc Scrc 1045 C57bl 6 Scrc, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hpscs sigma aldrich epithelial 1 ipsc0028 h9 hescs wicell wa09 mefs dr4 atcc scrc 1045 c57bl 6 scrc/product/ATCC
Average 96 stars, based on 1 article reviews
hpscs sigma aldrich epithelial 1 ipsc0028 h9 hescs wicell wa09 mefs dr4 atcc scrc 1045 c57bl 6 scrc - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

90
Novus Biologicals dgcr8 knockout
Simtron biogenesis involves Drosha but not <t>DGCR8.</t> Knockdown of DGCR8 in HeLa cells using siRNA was quantitated by ( A ) RT–PCR analysis of DGCR8 mRNA and ( B ) western blot analysis of DGCR8 protein expression. The percentage of knockdown of DGCR8 was quantitated for DGCR8 mRNA using the equation 100 − [(( DGCR8 knockdown / GAPDH )/( DGCR8 control / GAPDH )) × 100], n = 5 and for DGCR8 protein using the equation 100 − [(( DGCR8 knockdown /β-actin )/( DGCR8 control / β-actin )) × 100]. (C) Changes in endogenous miRNA levels following DGCR8 knockdown were analysed by stemloop RT–PCR analysis. miR-16 is a canonical miRNA control and sno65 is a loading control. Graph shows quantitation of miRNA abundance using the equation: (miRNA experimental condition /sno65)/(miRNA control /sno65). n = 4 for all miRNAs except for miR-16, n = 5; asterisk indicates P ≤ 0.05 (Wilcoxon matched pairs signed-rank test). M indicates a synthetic size marker and filled circle indicates a non-specific primer dimer. ( D ) RT–PCR analysis of Drosha mRNA following expression of TN-Drosha in HEK-293T cells. ( E ) The effect of TN-Drosha expression on endogenous miRNA abundance was analysed by stemloop RT–PCR. Graph shows quantitation of miRNA abundance using the same equation as in C, n = 6; asterick indicates P ≤ 0.05 (Student's t -test). ( F ) Stemloop RT–PCR analysis of minigene-derived miR-877, 1226, 1225, 1228 and endogenous miR-16 isolated from HEK-293T cells transiently transfected with TN-Drosha. sno65 was used as a control. TN-Drosha mRNA expression in HEK-293T cells was analysed by radiolabelled RT–PCR. GAPDH was used as a control. ( G ) Quantitation of miRNA abundance relative to sno65 using the equation: miRNA/sno65. n = 3 for miR-877, 1226 and 1225, n = 5 for miR-1228 and n = 14 for miR-16; * P ≤ 0.05, *** P ≤ 0.0001 (). Data sets were analysed using the Student's t -test with the exception of miR-16, which was analysed using the Wilcoxon matched pairs signed-rank test. In all panels, bars represent the average ± SEM. The horizontal dotted line indicates normalized control levels.
Dgcr8 Knockout, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dgcr8 knockout/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
dgcr8 knockout - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology anti mef2b
Simtron biogenesis involves Drosha but not <t>DGCR8.</t> Knockdown of DGCR8 in HeLa cells using siRNA was quantitated by ( A ) RT–PCR analysis of DGCR8 mRNA and ( B ) western blot analysis of DGCR8 protein expression. The percentage of knockdown of DGCR8 was quantitated for DGCR8 mRNA using the equation 100 − [(( DGCR8 knockdown / GAPDH )/( DGCR8 control / GAPDH )) × 100], n = 5 and for DGCR8 protein using the equation 100 − [(( DGCR8 knockdown /β-actin )/( DGCR8 control / β-actin )) × 100]. (C) Changes in endogenous miRNA levels following DGCR8 knockdown were analysed by stemloop RT–PCR analysis. miR-16 is a canonical miRNA control and sno65 is a loading control. Graph shows quantitation of miRNA abundance using the equation: (miRNA experimental condition /sno65)/(miRNA control /sno65). n = 4 for all miRNAs except for miR-16, n = 5; asterisk indicates P ≤ 0.05 (Wilcoxon matched pairs signed-rank test). M indicates a synthetic size marker and filled circle indicates a non-specific primer dimer. ( D ) RT–PCR analysis of Drosha mRNA following expression of TN-Drosha in HEK-293T cells. ( E ) The effect of TN-Drosha expression on endogenous miRNA abundance was analysed by stemloop RT–PCR. Graph shows quantitation of miRNA abundance using the same equation as in C, n = 6; asterick indicates P ≤ 0.05 (Student's t -test). ( F ) Stemloop RT–PCR analysis of minigene-derived miR-877, 1226, 1225, 1228 and endogenous miR-16 isolated from HEK-293T cells transiently transfected with TN-Drosha. sno65 was used as a control. TN-Drosha mRNA expression in HEK-293T cells was analysed by radiolabelled RT–PCR. GAPDH was used as a control. ( G ) Quantitation of miRNA abundance relative to sno65 using the equation: miRNA/sno65. n = 3 for miR-877, 1226 and 1225, n = 5 for miR-1228 and n = 14 for miR-16; * P ≤ 0.05, *** P ≤ 0.0001 (). Data sets were analysed using the Student's t -test with the exception of miR-16, which was analysed using the Wilcoxon matched pairs signed-rank test. In all panels, bars represent the average ± SEM. The horizontal dotted line indicates normalized control levels.
Anti Mef2b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mef2b/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
anti mef2b - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology mef2c
Testosterone-induced MEF2 activity in cardiac myocytes. Cells were transfected with MEF2 luciferase-reporter (MEF2-Luc) and Renilla luciferase plasmids. MEF2 activity is expressed as MEF2-Luc to Renilla luciferase ratio. (A) Cardiac myocytes were stimulated with 100 nM testosterone for 6–48 h ( n = 6). (B) Cells were treated with testosterone at the indicated concentrations for 24 h ( n = 6). IGF-1 treatment (10 nM, 24 h) was used as the positive control for MEF2 activity ( n = 6). (C) Cardiac myocytes were transfected with either <t>siRNA-MEF2C</t> or non-targeting siRNA. (D) Cardiac myocytes expressing MEF2-Luc were transfected with siRNA-MEF2C and stimulated with testosterone (100 nM) for 24 h ( n = 5). Cells transfected with the non-targeting siRNA served as the control. (E) Cells were stimulated with testosterone (100 nM) for 5–180 min and then subjected to immunofluorescent staining with an anti-MEF2C antibody; nuclei were stained with DAPI (blue). The figure shows representative images for control and stimulated conditions (30 min). (F) Quantification of MEF2C staining, shown as the nuclear-to-cytoplasmic fluorescence ratio. Data are presented as means ± SEM or as representative images. P -values were determined using t -test or ANOVA followed by Bonferroni post hoc test. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs. control; ### P < 0.001 vs. testosterone.
Mef2c, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef2c/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
mef2c - by Bioz Stars, 2026-06
88/100 stars
  Buy from Supplier

90
Novus Biologicals dgcr8 knockout mefs
UV-induced interactions between <t>DGCR8</t> and TC-NER factors require S153-phosphorylation. ( a ) Schematic overview of the experimental design and proximity ligation assay (PLA). ( b–f ) Quantification and representative PLA images showing interactions between DGCR8 and the specified TC-NER proteins. PLA signals (red) were detected in nuclei counterstained with DAPI (blue). U2-OS cells expressing either wild-type DGCR8 (left) or the S153A mutant (right) were irradiated with 20 J/m 2 UV-C and allowed to recover for 1, 2, or 4 h (purple dots); non-irradiated controls are shown in gray (UV-). Horizontal black bars indicate the median of each group. Asterisks indicate statistically significant differences relative to non-irradiated controls or between genotypes (* p < 0.05, ** p < 0.01, *** p < 0.001). White scale bars, 10 μm.
Dgcr8 Knockout Mefs, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dgcr8 knockout mefs/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
dgcr8 knockout mefs - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and MEF-BL/6–1 cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.

Journal: Frontiers in Immunology

Article Title: Mouse TAPBPR shows functional similarity to human TAPBPR in shaping the MHC-I immunopeptidome

doi: 10.3389/fimmu.2026.1756668

Figure Lengend Snippet: Feature of mouse TAPBPR protein. (A) ClustalWS alignment comparison between mouse TAPBPR (mouse TAPBPR, UniProt Q8VD31 ) and human TAPBPR (UniProt Q9BX59 ) proteins. Blosum62 scoring system was generated by Jalview 2.11.4.0 software. Boxes highlight the peptide editing loop (blue), MHC-I binding sites characterized as TN5, TN6, TC2 and TC3 (red), the free cysteine residue (black), two predicted N-linked glycosylation sites in mouse TAPBPR (purple, with the asparagine indicated by an asterisk) and the cytoplasmic tail regions (yellow). The endogenous mouse TAPBPR sequence in MC-38, B16-F10, and MEF-BL/6–1 cells was confirmed as equivalent to the UniProt reference. (B) Predicted AlphaFold2 structure of mouse TAPBPR (green) bound to H2-D b (blue) with N-linked glycosylations (pink) modelled using GLYCAM ( https://glycam.org ). For H2-D b , only two of the three glycans are visible in the image, with N86 obscured by the orientation depicted. (C) Representative histograms and bar graphs showing mean fluorescence intensity (MFI) of intracellular TAPBPR expression, detected using AnDi3 antibody, on IFNγ-treated wildtype (WT) MC-38, B16-F10, and MEF-BL/6–1 cells compared to TAPBPR knockout (KO) and mouse TAPBPR overexpressed (OE) equivalents, which serve as negative and positive controls, respectively. Error bars show MFI -/+ standard error of mean (SEM) from three independent experiments. *p ≤ 0.05, **p ≤ 0.01 using unpaired t-test. (D) Histograms showing IFNγ inducibility of intracellular TAPBPR expression in WT MC-38 and B16-F10 cells and in cells transduced to overexpress (OE) mouse TAPBPR.

Article Snippet: Murine colon adenocarcinoma MC-38 (Kerfast, Newark, CA 94560, USA), mouse melanoma B16-F10, Lewis lung carcinoma LL/2 and mouse stromal fibroblast MEF-BL/6-1 (ATCC SCRC-1008) cells were maintained in Dulbecco’s Modified Eagle’s medium (DMEM)(CAT: 41966052, GibcoTM, Thermo Fisher Scientific, Paisley, Renfrewshire, UK), supplemented with 10% fetal bovine serum (FBS)(CAT: 10500064, GibcoTM) and 100 units/mL penicillin-streptomycin (CAT: 15140122, GibcoTM) at 37 °C, 5% CO 2 , and humid atmosphere.

Techniques: Comparison, Generated, Software, Binding Assay, Residue, Glycoproteomics, Sequencing, Fluorescence, Expressing, Knock-Out

Mouse TAPBPR interaction partners identified in B16-F10, MC-38 and MEF-BL/6–1 cell lines. Mouse TAPBPR was isolated by immunoprecipitation, using Andi38 antibody, from TAPBPR knockout (KO) or mouse TAPBPR overexpressing (OE) from (A) B16-F10 cells, (B) MC-38 cells, (C) MEF-BL/6–1 cells or (D) MC-38 cells with β2m knocked out. Scatterplots show all proteins identified via mass spectrometry in the mouse TAPBPR pull-downs in cells overexpressing mouse TAPBPR compared to the equivalent TAPBPR KO cell line. Selected significant interaction partners highlighted are TAPBPR (pink), H2-D b (red), H2-K b (yellow), MHC-I (orange), which covers peptides common to H2 molecules and therefore cannot be assigned to a specific MHC-I molecule, β2m (navy) and known components of the MHC-I antigen presentation pathway (purple). (E) Confirmation of mouse TAPBPR binding partners at endogenous TAPBPR levels in MC-38 cells. Immunoblots indicating abundance of mouse TAPBPR (mTAPBPR), MHC-I, β2m, calnexin, tapasin, TAP2, and GAPDH (loading control) in the whole cell lysates and mouse TAPBPR immunoprecipitates (IP: mTAPBPR) from WT MC-38 cells. MC-38 with TAPBPR knocked out (KO) or overexpressing mouse TAPBPR (OE) are included as controls. Cells competent for β2m expression or with β2m knocked down (β2m KD) were compared to assess the importance of the TAPBPR/MHC-I interaction in the observed associations. An antibody-only lane is included to highlight the antibody’s heavy chain used in the immunoprecipitation. N = 1, for tapasin and TAP2 blot. (F) Endogenously expressed mouse TAPBPR exhibits a prolonged association with H2-D b compared to H2-K b in both MC-38 and B16 cells. Immunoblots indicating abundance of mTAPBPR, MHC-I, β2m, calnexin, and GAPDH (loading control) in the whole cell lysate and mTAPBPR immunoprecipitated fraction (IP: mTAPBPR) with Andi 38 from MC-38 or B16-F10 WT cells, and variant cell lines expressing H2-D b only (H2-K b knockout), H-2K b only (H2-D b knockout) or lacking efficient expression of both H2-D d and -K b following β2m knock down (KD). Representative of three independent experiments. Note: Arrowheads indicate the positioning of the major TAPBPR and MHC-I bands in the gels, where background bands were present in the immunoprecipitations. The position of TAPBPR relative to the antibody control also varies due to minor changes in running conditions between experiments. Note: WT cells in F were treated with a non-targeting RNA guide in the RNP.

Journal: Frontiers in Immunology

Article Title: Mouse TAPBPR shows functional similarity to human TAPBPR in shaping the MHC-I immunopeptidome

doi: 10.3389/fimmu.2026.1756668

Figure Lengend Snippet: Mouse TAPBPR interaction partners identified in B16-F10, MC-38 and MEF-BL/6–1 cell lines. Mouse TAPBPR was isolated by immunoprecipitation, using Andi38 antibody, from TAPBPR knockout (KO) or mouse TAPBPR overexpressing (OE) from (A) B16-F10 cells, (B) MC-38 cells, (C) MEF-BL/6–1 cells or (D) MC-38 cells with β2m knocked out. Scatterplots show all proteins identified via mass spectrometry in the mouse TAPBPR pull-downs in cells overexpressing mouse TAPBPR compared to the equivalent TAPBPR KO cell line. Selected significant interaction partners highlighted are TAPBPR (pink), H2-D b (red), H2-K b (yellow), MHC-I (orange), which covers peptides common to H2 molecules and therefore cannot be assigned to a specific MHC-I molecule, β2m (navy) and known components of the MHC-I antigen presentation pathway (purple). (E) Confirmation of mouse TAPBPR binding partners at endogenous TAPBPR levels in MC-38 cells. Immunoblots indicating abundance of mouse TAPBPR (mTAPBPR), MHC-I, β2m, calnexin, tapasin, TAP2, and GAPDH (loading control) in the whole cell lysates and mouse TAPBPR immunoprecipitates (IP: mTAPBPR) from WT MC-38 cells. MC-38 with TAPBPR knocked out (KO) or overexpressing mouse TAPBPR (OE) are included as controls. Cells competent for β2m expression or with β2m knocked down (β2m KD) were compared to assess the importance of the TAPBPR/MHC-I interaction in the observed associations. An antibody-only lane is included to highlight the antibody’s heavy chain used in the immunoprecipitation. N = 1, for tapasin and TAP2 blot. (F) Endogenously expressed mouse TAPBPR exhibits a prolonged association with H2-D b compared to H2-K b in both MC-38 and B16 cells. Immunoblots indicating abundance of mTAPBPR, MHC-I, β2m, calnexin, and GAPDH (loading control) in the whole cell lysate and mTAPBPR immunoprecipitated fraction (IP: mTAPBPR) with Andi 38 from MC-38 or B16-F10 WT cells, and variant cell lines expressing H2-D b only (H2-K b knockout), H-2K b only (H2-D b knockout) or lacking efficient expression of both H2-D d and -K b following β2m knock down (KD). Representative of three independent experiments. Note: Arrowheads indicate the positioning of the major TAPBPR and MHC-I bands in the gels, where background bands were present in the immunoprecipitations. The position of TAPBPR relative to the antibody control also varies due to minor changes in running conditions between experiments. Note: WT cells in F were treated with a non-targeting RNA guide in the RNP.

Article Snippet: Murine colon adenocarcinoma MC-38 (Kerfast, Newark, CA 94560, USA), mouse melanoma B16-F10, Lewis lung carcinoma LL/2 and mouse stromal fibroblast MEF-BL/6-1 (ATCC SCRC-1008) cells were maintained in Dulbecco’s Modified Eagle’s medium (DMEM)(CAT: 41966052, GibcoTM, Thermo Fisher Scientific, Paisley, Renfrewshire, UK), supplemented with 10% fetal bovine serum (FBS)(CAT: 10500064, GibcoTM) and 100 units/mL penicillin-streptomycin (CAT: 15140122, GibcoTM) at 37 °C, 5% CO 2 , and humid atmosphere.

Techniques: Isolation, Immunoprecipitation, Knock-Out, Mass Spectrometry, Immunopeptidomics, Binding Assay, Western Blot, Control, Expressing, Variant Assay, Knockdown

Simtron biogenesis involves Drosha but not DGCR8. Knockdown of DGCR8 in HeLa cells using siRNA was quantitated by ( A ) RT–PCR analysis of DGCR8 mRNA and ( B ) western blot analysis of DGCR8 protein expression. The percentage of knockdown of DGCR8 was quantitated for DGCR8 mRNA using the equation 100 − [(( DGCR8 knockdown / GAPDH )/( DGCR8 control / GAPDH )) × 100], n = 5 and for DGCR8 protein using the equation 100 − [(( DGCR8 knockdown /β-actin )/( DGCR8 control / β-actin )) × 100]. (C) Changes in endogenous miRNA levels following DGCR8 knockdown were analysed by stemloop RT–PCR analysis. miR-16 is a canonical miRNA control and sno65 is a loading control. Graph shows quantitation of miRNA abundance using the equation: (miRNA experimental condition /sno65)/(miRNA control /sno65). n = 4 for all miRNAs except for miR-16, n = 5; asterisk indicates P ≤ 0.05 (Wilcoxon matched pairs signed-rank test). M indicates a synthetic size marker and filled circle indicates a non-specific primer dimer. ( D ) RT–PCR analysis of Drosha mRNA following expression of TN-Drosha in HEK-293T cells. ( E ) The effect of TN-Drosha expression on endogenous miRNA abundance was analysed by stemloop RT–PCR. Graph shows quantitation of miRNA abundance using the same equation as in C, n = 6; asterick indicates P ≤ 0.05 (Student's t -test). ( F ) Stemloop RT–PCR analysis of minigene-derived miR-877, 1226, 1225, 1228 and endogenous miR-16 isolated from HEK-293T cells transiently transfected with TN-Drosha. sno65 was used as a control. TN-Drosha mRNA expression in HEK-293T cells was analysed by radiolabelled RT–PCR. GAPDH was used as a control. ( G ) Quantitation of miRNA abundance relative to sno65 using the equation: miRNA/sno65. n = 3 for miR-877, 1226 and 1225, n = 5 for miR-1228 and n = 14 for miR-16; * P ≤ 0.05, *** P ≤ 0.0001 (). Data sets were analysed using the Student's t -test with the exception of miR-16, which was analysed using the Wilcoxon matched pairs signed-rank test. In all panels, bars represent the average ± SEM. The horizontal dotted line indicates normalized control levels.

Journal: Nucleic Acids Research

Article Title: Biogenesis of mammalian microRNAs by a non-canonical processing pathway

doi: 10.1093/nar/gks026

Figure Lengend Snippet: Simtron biogenesis involves Drosha but not DGCR8. Knockdown of DGCR8 in HeLa cells using siRNA was quantitated by ( A ) RT–PCR analysis of DGCR8 mRNA and ( B ) western blot analysis of DGCR8 protein expression. The percentage of knockdown of DGCR8 was quantitated for DGCR8 mRNA using the equation 100 − [(( DGCR8 knockdown / GAPDH )/( DGCR8 control / GAPDH )) × 100], n = 5 and for DGCR8 protein using the equation 100 − [(( DGCR8 knockdown /β-actin )/( DGCR8 control / β-actin )) × 100]. (C) Changes in endogenous miRNA levels following DGCR8 knockdown were analysed by stemloop RT–PCR analysis. miR-16 is a canonical miRNA control and sno65 is a loading control. Graph shows quantitation of miRNA abundance using the equation: (miRNA experimental condition /sno65)/(miRNA control /sno65). n = 4 for all miRNAs except for miR-16, n = 5; asterisk indicates P ≤ 0.05 (Wilcoxon matched pairs signed-rank test). M indicates a synthetic size marker and filled circle indicates a non-specific primer dimer. ( D ) RT–PCR analysis of Drosha mRNA following expression of TN-Drosha in HEK-293T cells. ( E ) The effect of TN-Drosha expression on endogenous miRNA abundance was analysed by stemloop RT–PCR. Graph shows quantitation of miRNA abundance using the same equation as in C, n = 6; asterick indicates P ≤ 0.05 (Student's t -test). ( F ) Stemloop RT–PCR analysis of minigene-derived miR-877, 1226, 1225, 1228 and endogenous miR-16 isolated from HEK-293T cells transiently transfected with TN-Drosha. sno65 was used as a control. TN-Drosha mRNA expression in HEK-293T cells was analysed by radiolabelled RT–PCR. GAPDH was used as a control. ( G ) Quantitation of miRNA abundance relative to sno65 using the equation: miRNA/sno65. n = 3 for miR-877, 1226 and 1225, n = 5 for miR-1228 and n = 14 for miR-16; * P ≤ 0.05, *** P ≤ 0.0001 (). Data sets were analysed using the Student's t -test with the exception of miR-16, which was analysed using the Wilcoxon matched pairs signed-rank test. In all panels, bars represent the average ± SEM. The horizontal dotted line indicates normalized control levels.

Article Snippet: Hannon) ( ) and DGCR8 knockout (DGCR8 −/− ) cells (Novus Biologicals) were grown on a gelatin layer in Knockout Dulbecco's modified Eagle's medium (Gibco) supplemented with 15% ES cell FBS (Gibco), 1% non-essential amino acids, 1% l -glutamine, 1% penicillin/streptomycin/Amphotericin B, 0.1% ESGRO-LIF and 0.008% beta-mercaptoethanol.

Techniques: Knockdown, Reverse Transcription Polymerase Chain Reaction, Western Blot, Expressing, Control, Quantitation Assay, Marker, Derivative Assay, Isolation, Transfection

Simtron biogenesis does not require DGCR8, Dicer, Ago2 or XPO5. ( A ) RT–PCR analysis of minigene-derived host gene mRNA and stemloop RT–PCR analysis of minigene-derived miRNA and endogenous miR-16 in Dicer and DGCR8 knockout mouse embryonic stem cells transfected with the wt or splicing-deficient minigene (Δss) or empty vector control (−). sno65 was used as a loading control. Graphs show quantitation of miRNA using the equation: (miRNA experimental condition /sno65)/(miRNA control /sno65). Bars represent the average ± SEM, n = 3. The horizontal dotted lines indicate normalized control levels. ( B ) Stemloop RT–PCR analysis of miR-1225 and miR-1228 immunoprecipitated from HEK-293T cell lysates that were transiently transfected with wt or Δss minigenes, or miR-877 from wt minigene along with pFLAG-Dicer (Dicer) or without (−) and immunoprecipitated with an antibody against the FLAG epitope. Input refers to cell lysates before FLAG immunoprecipitation; Un is the unbound fraction and IP is the immunoprecipitated fraction. Un is 1/20 IP and Input is 1/5 IP. The graph represents the percent of the mature miRNA found in the IP fraction versus the amount that remained in the Un fraction using the equation: (IP/(IP + (Un × 20)) × 100). ( C ) Stemloop RT–PCR analysis of minigene-derived miR-1225, miR-1228 and endogenous miR-16 from Ago2 knockout mouse embryonic fibroblasts. sno65 was used as a loading control. Cells were transiently transfected with wt or Δss minigenes or empty vector control (−). Graph shows quantitation of miRNA abundance using the same equation as in A. Bars represent the average ± SEM, n = 3 and * P ≤ 0.05 or ** P ≤ 0.01, Student's t -test. The horizontal dotted lines indicate normalized control levels. ( D ) Stemloop RT–PCR and RT–PCR analysis of miR-877 (left panel), miR-1225 (middle panel) and miR-1228 (right panel) minigene-expression in HeLa cells following siRNA-directed knockdown of XPO5 . sno65 is a loading control for miRNA using stemloop RT–PCR and GAPDH is a loading control for RT–PCR of XPO5 mRNA.

Journal: Nucleic Acids Research

Article Title: Biogenesis of mammalian microRNAs by a non-canonical processing pathway

doi: 10.1093/nar/gks026

Figure Lengend Snippet: Simtron biogenesis does not require DGCR8, Dicer, Ago2 or XPO5. ( A ) RT–PCR analysis of minigene-derived host gene mRNA and stemloop RT–PCR analysis of minigene-derived miRNA and endogenous miR-16 in Dicer and DGCR8 knockout mouse embryonic stem cells transfected with the wt or splicing-deficient minigene (Δss) or empty vector control (−). sno65 was used as a loading control. Graphs show quantitation of miRNA using the equation: (miRNA experimental condition /sno65)/(miRNA control /sno65). Bars represent the average ± SEM, n = 3. The horizontal dotted lines indicate normalized control levels. ( B ) Stemloop RT–PCR analysis of miR-1225 and miR-1228 immunoprecipitated from HEK-293T cell lysates that were transiently transfected with wt or Δss minigenes, or miR-877 from wt minigene along with pFLAG-Dicer (Dicer) or without (−) and immunoprecipitated with an antibody against the FLAG epitope. Input refers to cell lysates before FLAG immunoprecipitation; Un is the unbound fraction and IP is the immunoprecipitated fraction. Un is 1/20 IP and Input is 1/5 IP. The graph represents the percent of the mature miRNA found in the IP fraction versus the amount that remained in the Un fraction using the equation: (IP/(IP + (Un × 20)) × 100). ( C ) Stemloop RT–PCR analysis of minigene-derived miR-1225, miR-1228 and endogenous miR-16 from Ago2 knockout mouse embryonic fibroblasts. sno65 was used as a loading control. Cells were transiently transfected with wt or Δss minigenes or empty vector control (−). Graph shows quantitation of miRNA abundance using the same equation as in A. Bars represent the average ± SEM, n = 3 and * P ≤ 0.05 or ** P ≤ 0.01, Student's t -test. The horizontal dotted lines indicate normalized control levels. ( D ) Stemloop RT–PCR and RT–PCR analysis of miR-877 (left panel), miR-1225 (middle panel) and miR-1228 (right panel) minigene-expression in HeLa cells following siRNA-directed knockdown of XPO5 . sno65 is a loading control for miRNA using stemloop RT–PCR and GAPDH is a loading control for RT–PCR of XPO5 mRNA.

Article Snippet: Hannon) ( ) and DGCR8 knockout (DGCR8 −/− ) cells (Novus Biologicals) were grown on a gelatin layer in Knockout Dulbecco's modified Eagle's medium (Gibco) supplemented with 15% ES cell FBS (Gibco), 1% non-essential amino acids, 1% l -glutamine, 1% penicillin/streptomycin/Amphotericin B, 0.1% ESGRO-LIF and 0.008% beta-mercaptoethanol.

Techniques: Reverse Transcription Polymerase Chain Reaction, Derivative Assay, Knock-Out, Transfection, Plasmid Preparation, Control, Quantitation Assay, Immunoprecipitation, FLAG-tag, Expressing, Knockdown

Immunoprecipitation and in vitro processing of simtrons with Drosha. ( A ) Pre-miR-1225 co-immunoprecipitates with Drosha. Pre-miR-1225 derived from wt and Δss minigenes and pre-miR-877 from wt minigene were transiently transfected into HEK-293T cells with pFLAG-Drosha (Drosha) or without (−), and immunoprecipitated with an antibody against the FLAG epitope. Isolated pre-miRNAs were analysed by radiolabelled stemloop RT–PCR and products were separated by 12% native PAGE. Input (In) refers to cell lysates before FLAG immunoprecipitation; Un is the unbound fraction and IP is the immunoprecipitated fraction. Un is 1/20 IP and Input is 1/5 IP. The graph represents the percent of the pre-miRNA found in the IP fraction versus the amount that remained in the Un fraction using the equation: (IP/(IP + (Un × 20)) × 100). ( B ) Drosha-dependent in vitro simtron processing. Radiolabelled RNA transcribed from a PKD1 wt or Δss, ABCF1 wt or pri-miR-16-1 DNA template was incubated with the FLAG-immunoprecipitates from HEK-293T cells, or with HEK-293T WCEs from cells that were not transfected. FLAG-immunoprecipitates were derived from cells transfected with mock transfection (−), pFLAG-GFP (GFP), pFLAG-Drosha (Drosha), pFLAG-Drosha and pFLAG-DGCR8 (Drosha + DGCR8), pFLAG-TN-Drosha (TN Drosha), or FLAG-M2-beads that were incubated with lysis buffer but no cell lysate (−lysate). Template RNA was included as a control (RNA). Reaction products were separated by 8% denaturing PAGE. The sizes of pre-miRNAs are indicated. Asterisk indicates uncharacterized miR-16 cleavage fragments .

Journal: Nucleic Acids Research

Article Title: Biogenesis of mammalian microRNAs by a non-canonical processing pathway

doi: 10.1093/nar/gks026

Figure Lengend Snippet: Immunoprecipitation and in vitro processing of simtrons with Drosha. ( A ) Pre-miR-1225 co-immunoprecipitates with Drosha. Pre-miR-1225 derived from wt and Δss minigenes and pre-miR-877 from wt minigene were transiently transfected into HEK-293T cells with pFLAG-Drosha (Drosha) or without (−), and immunoprecipitated with an antibody against the FLAG epitope. Isolated pre-miRNAs were analysed by radiolabelled stemloop RT–PCR and products were separated by 12% native PAGE. Input (In) refers to cell lysates before FLAG immunoprecipitation; Un is the unbound fraction and IP is the immunoprecipitated fraction. Un is 1/20 IP and Input is 1/5 IP. The graph represents the percent of the pre-miRNA found in the IP fraction versus the amount that remained in the Un fraction using the equation: (IP/(IP + (Un × 20)) × 100). ( B ) Drosha-dependent in vitro simtron processing. Radiolabelled RNA transcribed from a PKD1 wt or Δss, ABCF1 wt or pri-miR-16-1 DNA template was incubated with the FLAG-immunoprecipitates from HEK-293T cells, or with HEK-293T WCEs from cells that were not transfected. FLAG-immunoprecipitates were derived from cells transfected with mock transfection (−), pFLAG-GFP (GFP), pFLAG-Drosha (Drosha), pFLAG-Drosha and pFLAG-DGCR8 (Drosha + DGCR8), pFLAG-TN-Drosha (TN Drosha), or FLAG-M2-beads that were incubated with lysis buffer but no cell lysate (−lysate). Template RNA was included as a control (RNA). Reaction products were separated by 8% denaturing PAGE. The sizes of pre-miRNAs are indicated. Asterisk indicates uncharacterized miR-16 cleavage fragments .

Article Snippet: Hannon) ( ) and DGCR8 knockout (DGCR8 −/− ) cells (Novus Biologicals) were grown on a gelatin layer in Knockout Dulbecco's modified Eagle's medium (Gibco) supplemented with 15% ES cell FBS (Gibco), 1% non-essential amino acids, 1% l -glutamine, 1% penicillin/streptomycin/Amphotericin B, 0.1% ESGRO-LIF and 0.008% beta-mercaptoethanol.

Techniques: Immunoprecipitation, In Vitro, Derivative Assay, Transfection, FLAG-tag, Isolation, Reverse Transcription Polymerase Chain Reaction, Clear Native PAGE, Incubation, Lysis, Control

Simtron processing is context independent. ( A ) Diagram comparing intronic and intergenic pre-miRNA expression. ( B ) Control, Dicer (Dicer −/− ) or DGCR8 (DGCR8 −/− ) knockout mouse embryonic stem cells were transiently transfected with the intergenic wt minigene, or intergenic splicing-deficient minigene (Δss). Minigene-derived miRNAs and endogenous miR-16 were analysed by stemloop RT–PCR. Left panel: simtron miR-1225. Right panel: mirtron miR-877. sno65 was analysed as a loading control. ( C ) Graph shows quantitation of miR-1225 abundance using the equation: (miRNA Dicer−/− or DGCR8−/− /sno65)/(miRNA control /sno65). Bars represent the average values ±SEM, n = 4 for Dicer −/− and n = 3 for DGCR8 −/− . The horizontal dotted line indicates normalized control cell levels.

Journal: Nucleic Acids Research

Article Title: Biogenesis of mammalian microRNAs by a non-canonical processing pathway

doi: 10.1093/nar/gks026

Figure Lengend Snippet: Simtron processing is context independent. ( A ) Diagram comparing intronic and intergenic pre-miRNA expression. ( B ) Control, Dicer (Dicer −/− ) or DGCR8 (DGCR8 −/− ) knockout mouse embryonic stem cells were transiently transfected with the intergenic wt minigene, or intergenic splicing-deficient minigene (Δss). Minigene-derived miRNAs and endogenous miR-16 were analysed by stemloop RT–PCR. Left panel: simtron miR-1225. Right panel: mirtron miR-877. sno65 was analysed as a loading control. ( C ) Graph shows quantitation of miR-1225 abundance using the equation: (miRNA Dicer−/− or DGCR8−/− /sno65)/(miRNA control /sno65). Bars represent the average values ±SEM, n = 4 for Dicer −/− and n = 3 for DGCR8 −/− . The horizontal dotted line indicates normalized control cell levels.

Article Snippet: Hannon) ( ) and DGCR8 knockout (DGCR8 −/− ) cells (Novus Biologicals) were grown on a gelatin layer in Knockout Dulbecco's modified Eagle's medium (Gibco) supplemented with 15% ES cell FBS (Gibco), 1% non-essential amino acids, 1% l -glutamine, 1% penicillin/streptomycin/Amphotericin B, 0.1% ESGRO-LIF and 0.008% beta-mercaptoethanol.

Techniques: Expressing, Control, Knock-Out, Transfection, Derivative Assay, Reverse Transcription Polymerase Chain Reaction, Quantitation Assay

Proposed model of simtron biogenesis compared to other miRNA processing pathways. The pathways shown begin with the primary transcript and end with the mature product. Left: simtron pathway, Middle: mirtron pathway, Right: canonical miRNA pathway. Exons are depicted as boxes and introns and miRNAs as lines. Each protein or protein complex is labelled. Proteins labelled with question marks are proposed but not known. Simtrons (such as miR-1225 and miR-1228) processing from the intron involves Drosha and possibly an unknown binding partner. Simtrons are further processed by unknown factors and enter the RISC complex with any of the four human Argonaute proteins. Mirtrons (such as miR-877 and miR-1226) are excised from the host gene by the spliceosome, are debranched, exported from the nucleus by exportin5 (XPO5), cleaved by Dicer and enter the RISC complex. Canonical miRNAs (such as miR-16) are processed by Drosha and DGCR8, exported from the nucleus by XPO5, cleaved by Dicer and enter the RISC complex. All three pathways result in functional miRNAs.

Journal: Nucleic Acids Research

Article Title: Biogenesis of mammalian microRNAs by a non-canonical processing pathway

doi: 10.1093/nar/gks026

Figure Lengend Snippet: Proposed model of simtron biogenesis compared to other miRNA processing pathways. The pathways shown begin with the primary transcript and end with the mature product. Left: simtron pathway, Middle: mirtron pathway, Right: canonical miRNA pathway. Exons are depicted as boxes and introns and miRNAs as lines. Each protein or protein complex is labelled. Proteins labelled with question marks are proposed but not known. Simtrons (such as miR-1225 and miR-1228) processing from the intron involves Drosha and possibly an unknown binding partner. Simtrons are further processed by unknown factors and enter the RISC complex with any of the four human Argonaute proteins. Mirtrons (such as miR-877 and miR-1226) are excised from the host gene by the spliceosome, are debranched, exported from the nucleus by exportin5 (XPO5), cleaved by Dicer and enter the RISC complex. Canonical miRNAs (such as miR-16) are processed by Drosha and DGCR8, exported from the nucleus by XPO5, cleaved by Dicer and enter the RISC complex. All three pathways result in functional miRNAs.

Article Snippet: Hannon) ( ) and DGCR8 knockout (DGCR8 −/− ) cells (Novus Biologicals) were grown on a gelatin layer in Knockout Dulbecco's modified Eagle's medium (Gibco) supplemented with 15% ES cell FBS (Gibco), 1% non-essential amino acids, 1% l -glutamine, 1% penicillin/streptomycin/Amphotericin B, 0.1% ESGRO-LIF and 0.008% beta-mercaptoethanol.

Techniques: Binding Assay, Functional Assay

Testosterone-induced MEF2 activity in cardiac myocytes. Cells were transfected with MEF2 luciferase-reporter (MEF2-Luc) and Renilla luciferase plasmids. MEF2 activity is expressed as MEF2-Luc to Renilla luciferase ratio. (A) Cardiac myocytes were stimulated with 100 nM testosterone for 6–48 h ( n = 6). (B) Cells were treated with testosterone at the indicated concentrations for 24 h ( n = 6). IGF-1 treatment (10 nM, 24 h) was used as the positive control for MEF2 activity ( n = 6). (C) Cardiac myocytes were transfected with either siRNA-MEF2C or non-targeting siRNA. (D) Cardiac myocytes expressing MEF2-Luc were transfected with siRNA-MEF2C and stimulated with testosterone (100 nM) for 24 h ( n = 5). Cells transfected with the non-targeting siRNA served as the control. (E) Cells were stimulated with testosterone (100 nM) for 5–180 min and then subjected to immunofluorescent staining with an anti-MEF2C antibody; nuclei were stained with DAPI (blue). The figure shows representative images for control and stimulated conditions (30 min). (F) Quantification of MEF2C staining, shown as the nuclear-to-cytoplasmic fluorescence ratio. Data are presented as means ± SEM or as representative images. P -values were determined using t -test or ANOVA followed by Bonferroni post hoc test. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs. control; ### P < 0.001 vs. testosterone.

Journal: Frontiers in Pharmacology

Article Title: Ca 2+ /Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy

doi: 10.3389/fphar.2017.00604

Figure Lengend Snippet: Testosterone-induced MEF2 activity in cardiac myocytes. Cells were transfected with MEF2 luciferase-reporter (MEF2-Luc) and Renilla luciferase plasmids. MEF2 activity is expressed as MEF2-Luc to Renilla luciferase ratio. (A) Cardiac myocytes were stimulated with 100 nM testosterone for 6–48 h ( n = 6). (B) Cells were treated with testosterone at the indicated concentrations for 24 h ( n = 6). IGF-1 treatment (10 nM, 24 h) was used as the positive control for MEF2 activity ( n = 6). (C) Cardiac myocytes were transfected with either siRNA-MEF2C or non-targeting siRNA. (D) Cardiac myocytes expressing MEF2-Luc were transfected with siRNA-MEF2C and stimulated with testosterone (100 nM) for 24 h ( n = 5). Cells transfected with the non-targeting siRNA served as the control. (E) Cells were stimulated with testosterone (100 nM) for 5–180 min and then subjected to immunofluorescent staining with an anti-MEF2C antibody; nuclei were stained with DAPI (blue). The figure shows representative images for control and stimulated conditions (30 min). (F) Quantification of MEF2C staining, shown as the nuclear-to-cytoplasmic fluorescence ratio. Data are presented as means ± SEM or as representative images. P -values were determined using t -test or ANOVA followed by Bonferroni post hoc test. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs. control; ### P < 0.001 vs. testosterone.

Article Snippet: The following reagents were from commercial sources: testosterone, bicalutamide, AIP, and 5-bromo-2-deoxyuridine (BrdU), Sigma-Aldrich (St. Louis, MO, United States); anti-phospho-CaMKII (Thr286, cat. # 3361), anti-MEF2C (cat. # 5030) and anti-phospholamban (PLN, cat. # 14562) antibodies, Cell Signaling Technology (Danvers, MA, United States); CellTracker Green (5-chloromethyl fluorescein diacetate) from Thermo-Fisher Scientific (Rockford, IL, United States); anti-phospho-PLN (Thr17, cat. # sc-24565), anti-CaMKII (cat. # sc-5392) and anti-AR (cat. # sc-815) antibodies and siRNAs targeting CaMKIIδ (cat. # sc-38953), AR (cat. # sc-29204), and MEF2C (cat. # sc-38062), Santa Cruz Biotechnology (Santa Cruz, CA, United States); [ 3 H]-leucine, NEN Radiochemicals Perkin Elmer (Waltham, MA, United States); and collagenase type II, Worthington Biochemical Corporation (Lakewood, CA, United States).

Techniques: Activity Assay, Transfection, Luciferase, Positive Control, Expressing, Control, Staining, Fluorescence

Effect of inhibition of CaMKII, MEF2C, and AR on testosterone-induced cardiac myocyte hypertrophy. Cell area and [ 3 H]-leucine incorporation were evaluated as hypertrophy parameters. Cells were treated with 100 nM testosterone for 48 h after (A,B) pretreatment with 1 μM bicalutamide, (C,D) transfection with siRNA-AR, (E,F) pretreatment with 1 μM AIP, or (G,H) transfection with siRNA-MEF2C. Cellular area was assessed using the vital fluorescent dye CellTracker Green ( n = 100 cells per condition from 5 independent cultures). Incorporation of [ 3 H]-leucine was quantified using a liquid scintillation counter, and values are expressed as counts⋅min -1 ⋅(μg of protein) -1 with respect to control non-stimulated conditions ( n = 5). Data are presented as means ± SEM. P -values were determined using ANOVA followed by Bonferroni post hoc test; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . control; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. testosterone.

Journal: Frontiers in Pharmacology

Article Title: Ca 2+ /Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy

doi: 10.3389/fphar.2017.00604

Figure Lengend Snippet: Effect of inhibition of CaMKII, MEF2C, and AR on testosterone-induced cardiac myocyte hypertrophy. Cell area and [ 3 H]-leucine incorporation were evaluated as hypertrophy parameters. Cells were treated with 100 nM testosterone for 48 h after (A,B) pretreatment with 1 μM bicalutamide, (C,D) transfection with siRNA-AR, (E,F) pretreatment with 1 μM AIP, or (G,H) transfection with siRNA-MEF2C. Cellular area was assessed using the vital fluorescent dye CellTracker Green ( n = 100 cells per condition from 5 independent cultures). Incorporation of [ 3 H]-leucine was quantified using a liquid scintillation counter, and values are expressed as counts⋅min -1 ⋅(μg of protein) -1 with respect to control non-stimulated conditions ( n = 5). Data are presented as means ± SEM. P -values were determined using ANOVA followed by Bonferroni post hoc test; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs . control; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. testosterone.

Article Snippet: The following reagents were from commercial sources: testosterone, bicalutamide, AIP, and 5-bromo-2-deoxyuridine (BrdU), Sigma-Aldrich (St. Louis, MO, United States); anti-phospho-CaMKII (Thr286, cat. # 3361), anti-MEF2C (cat. # 5030) and anti-phospholamban (PLN, cat. # 14562) antibodies, Cell Signaling Technology (Danvers, MA, United States); CellTracker Green (5-chloromethyl fluorescein diacetate) from Thermo-Fisher Scientific (Rockford, IL, United States); anti-phospho-PLN (Thr17, cat. # sc-24565), anti-CaMKII (cat. # sc-5392) and anti-AR (cat. # sc-815) antibodies and siRNAs targeting CaMKIIδ (cat. # sc-38953), AR (cat. # sc-29204), and MEF2C (cat. # sc-38062), Santa Cruz Biotechnology (Santa Cruz, CA, United States); [ 3 H]-leucine, NEN Radiochemicals Perkin Elmer (Waltham, MA, United States); and collagenase type II, Worthington Biochemical Corporation (Lakewood, CA, United States).

Techniques: Inhibition, Transfection, Control

Testosterone increases CaMKII activity and MEF2C and AR protein expression in cardiac hypertrophy in vivo. Extracts of homogenized left-ventricle tissue from the different rat groups were subjected to western blot to measure (A) CaMKII phosphorylation at Thr286 and total CaMKII protein levels, and (B) PLN Thr17 phosphorylation and total protein levels ( n = 6); in these two panels, the values shown are phosphorylated-to-total protein ratios. (C) MEF2C and (D) AR protein levels were determined through western blotting; β-actin was used as the loading control. Data are presented as means ± SEM; P -values were determined using ANOVA followed by Bonferroni post hoc test; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs. control; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. ORX group.

Journal: Frontiers in Pharmacology

Article Title: Ca 2+ /Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy

doi: 10.3389/fphar.2017.00604

Figure Lengend Snippet: Testosterone increases CaMKII activity and MEF2C and AR protein expression in cardiac hypertrophy in vivo. Extracts of homogenized left-ventricle tissue from the different rat groups were subjected to western blot to measure (A) CaMKII phosphorylation at Thr286 and total CaMKII protein levels, and (B) PLN Thr17 phosphorylation and total protein levels ( n = 6); in these two panels, the values shown are phosphorylated-to-total protein ratios. (C) MEF2C and (D) AR protein levels were determined through western blotting; β-actin was used as the loading control. Data are presented as means ± SEM; P -values were determined using ANOVA followed by Bonferroni post hoc test; ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001 vs. control; # P < 0.05, ## P < 0.01, ### P < 0.001 vs. ORX group.

Article Snippet: The following reagents were from commercial sources: testosterone, bicalutamide, AIP, and 5-bromo-2-deoxyuridine (BrdU), Sigma-Aldrich (St. Louis, MO, United States); anti-phospho-CaMKII (Thr286, cat. # 3361), anti-MEF2C (cat. # 5030) and anti-phospholamban (PLN, cat. # 14562) antibodies, Cell Signaling Technology (Danvers, MA, United States); CellTracker Green (5-chloromethyl fluorescein diacetate) from Thermo-Fisher Scientific (Rockford, IL, United States); anti-phospho-PLN (Thr17, cat. # sc-24565), anti-CaMKII (cat. # sc-5392) and anti-AR (cat. # sc-815) antibodies and siRNAs targeting CaMKIIδ (cat. # sc-38953), AR (cat. # sc-29204), and MEF2C (cat. # sc-38062), Santa Cruz Biotechnology (Santa Cruz, CA, United States); [ 3 H]-leucine, NEN Radiochemicals Perkin Elmer (Waltham, MA, United States); and collagenase type II, Worthington Biochemical Corporation (Lakewood, CA, United States).

Techniques: Activity Assay, Expressing, In Vivo, Western Blot, Phospho-proteomics, Control

UV-induced interactions between DGCR8 and TC-NER factors require S153-phosphorylation. ( a ) Schematic overview of the experimental design and proximity ligation assay (PLA). ( b–f ) Quantification and representative PLA images showing interactions between DGCR8 and the specified TC-NER proteins. PLA signals (red) were detected in nuclei counterstained with DAPI (blue). U2-OS cells expressing either wild-type DGCR8 (left) or the S153A mutant (right) were irradiated with 20 J/m 2 UV-C and allowed to recover for 1, 2, or 4 h (purple dots); non-irradiated controls are shown in gray (UV-). Horizontal black bars indicate the median of each group. Asterisks indicate statistically significant differences relative to non-irradiated controls or between genotypes (* p < 0.05, ** p < 0.01, *** p < 0.001). White scale bars, 10 μm.

Journal: Scientific Reports

Article Title: DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair

doi: 10.1038/s41598-026-38338-5

Figure Lengend Snippet: UV-induced interactions between DGCR8 and TC-NER factors require S153-phosphorylation. ( a ) Schematic overview of the experimental design and proximity ligation assay (PLA). ( b–f ) Quantification and representative PLA images showing interactions between DGCR8 and the specified TC-NER proteins. PLA signals (red) were detected in nuclei counterstained with DAPI (blue). U2-OS cells expressing either wild-type DGCR8 (left) or the S153A mutant (right) were irradiated with 20 J/m 2 UV-C and allowed to recover for 1, 2, or 4 h (purple dots); non-irradiated controls are shown in gray (UV-). Horizontal black bars indicate the median of each group. Asterisks indicate statistically significant differences relative to non-irradiated controls or between genotypes (* p < 0.05, ** p < 0.01, *** p < 0.001). White scale bars, 10 μm.

Article Snippet: Dgcr8 -knockout MEFs were purchased from Novus Biologicals and cultured according to the manufacturer’s instructions.

Techniques: Phospho-proteomics, Proximity Ligation Assay, Expressing, Mutagenesis, Irradiation

UV-induced TC-NER complex formation requires S153-phosphorylation. ( a–f ) Quantification and representative PLA images showing interactions between the specified TC-NER proteins. PLA signals (red) detected in nuclei counterstained with DAPI (blue). U2-OS cells expressing either wild-type DGCR8 (left) or the S153A mutant (right) were irradiated with 20 J/m² UV-C and allowed to recover for 1, 2, or 4 h (purple dots); non-irradiated controls are shown in gray (UV-). Horizontal black bars indicate the median of each group. Asterisks indicate statistically significant differences relative to non-irradiated controls or between genotypes (* p < 0.05, ** p < 0.01, *** p < 0.001). White scale bars, 10 μm. ( g ) Schematic model illustrating the proposed DGCR8-centered protein interaction network in response to UV.

Journal: Scientific Reports

Article Title: DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair

doi: 10.1038/s41598-026-38338-5

Figure Lengend Snippet: UV-induced TC-NER complex formation requires S153-phosphorylation. ( a–f ) Quantification and representative PLA images showing interactions between the specified TC-NER proteins. PLA signals (red) detected in nuclei counterstained with DAPI (blue). U2-OS cells expressing either wild-type DGCR8 (left) or the S153A mutant (right) were irradiated with 20 J/m² UV-C and allowed to recover for 1, 2, or 4 h (purple dots); non-irradiated controls are shown in gray (UV-). Horizontal black bars indicate the median of each group. Asterisks indicate statistically significant differences relative to non-irradiated controls or between genotypes (* p < 0.05, ** p < 0.01, *** p < 0.001). White scale bars, 10 μm. ( g ) Schematic model illustrating the proposed DGCR8-centered protein interaction network in response to UV.

Article Snippet: Dgcr8 -knockout MEFs were purchased from Novus Biologicals and cultured according to the manufacturer’s instructions.

Techniques: Phospho-proteomics, Expressing, Mutagenesis, Irradiation

S153A mutation disrupts UV-induced interactions between DGCR8 and TC-NER factors in MEFs. (a, b) Quantification and representative PLA images showing CSB–CSA ( a ) and DGCR8–CSB ( b ) interactions in MEFs. Wild-type, heterozygous (wt/S153A), and homozygous (S153A/S153A) MEFs were irradiated with 10 J/m 2 UV-C (purple dots) or left untreated (gray dots), followed by 2 hours of recovery. PLA signals (red) were detected in nuclei counterstained with DAPI (blue). Horizontal black bars indicate the median of each group. Asterisks denote significant differences relative to non-irradiated or between genotypes (*** p < 0.001). White scale bars, 10 μm.

Journal: Scientific Reports

Article Title: DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair

doi: 10.1038/s41598-026-38338-5

Figure Lengend Snippet: S153A mutation disrupts UV-induced interactions between DGCR8 and TC-NER factors in MEFs. (a, b) Quantification and representative PLA images showing CSB–CSA ( a ) and DGCR8–CSB ( b ) interactions in MEFs. Wild-type, heterozygous (wt/S153A), and homozygous (S153A/S153A) MEFs were irradiated with 10 J/m 2 UV-C (purple dots) or left untreated (gray dots), followed by 2 hours of recovery. PLA signals (red) were detected in nuclei counterstained with DAPI (blue). Horizontal black bars indicate the median of each group. Asterisks denote significant differences relative to non-irradiated or between genotypes (*** p < 0.001). White scale bars, 10 μm.

Article Snippet: Dgcr8 -knockout MEFs were purchased from Novus Biologicals and cultured according to the manufacturer’s instructions.

Techniques: Mutagenesis, Irradiation

DGCR8 interacts with chromatin remodelers and may act as a molecular switch in response to UV irradiation. (a, b) Representative PLA images showing interactions between DGCR8 and SPT16 or SMARCA5 ( a ) and interactions between phosphorylated S153-DGCR8 (pS153) and Drosha or CSA ( b ). U2-OS cells were irradiated with 20 J/m 2 UV-C (purple) or left untreated (gray), followed by 1, 2, or 4 h of recovery. White scale bars, 10 μm. ( c ) Quantification of PLA signals shown in (a) and (b). PLA signals (red) were detected and quantified in nuclei counterstained with DAPI (blue). Horizontal black bars indicate the median of each group. Asterisks denote significant differences relative to untreated cells (*** p < 0.001).

Journal: Scientific Reports

Article Title: DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair

doi: 10.1038/s41598-026-38338-5

Figure Lengend Snippet: DGCR8 interacts with chromatin remodelers and may act as a molecular switch in response to UV irradiation. (a, b) Representative PLA images showing interactions between DGCR8 and SPT16 or SMARCA5 ( a ) and interactions between phosphorylated S153-DGCR8 (pS153) and Drosha or CSA ( b ). U2-OS cells were irradiated with 20 J/m 2 UV-C (purple) or left untreated (gray), followed by 1, 2, or 4 h of recovery. White scale bars, 10 μm. ( c ) Quantification of PLA signals shown in (a) and (b). PLA signals (red) were detected and quantified in nuclei counterstained with DAPI (blue). Horizontal black bars indicate the median of each group. Asterisks denote significant differences relative to untreated cells (*** p < 0.001).

Article Snippet: Dgcr8 -knockout MEFs were purchased from Novus Biologicals and cultured according to the manufacturer’s instructions.

Techniques: Irradiation

DGCR8-pS153 contributes to R-loop regulation. ( a ) R-loop detection by S9.6 immunostaining in Dgcr8 −/− MEFs transduced with wild-type human DGCR8, the S153A mutant, or an empty vector. Note that the vertical axis scale differs due to microscope camera settings (see Methods). White scale bars, 10 μm. ( b ) S9.6 immunostaining in wild-type and S153A U2-OS cells. ( c ) Schematic of the R-loop probe: a catalytically inactive RNase H1 mutant (D210N) fused to EGFP (mRNH) was used to visualize R-loops in live or fixed cells. ( d ) Colocalization of R-loops with nucleoli in non-irradiated U2-OS cells, with nucleoli labeled using Nucleolus Bright Red (Dojin). (e, f) PLA analyses of interactions between DGCR8 and R-loops ( e ) and between R-loops and UV-induced cyclobutane pyrimidine dimers (CPDs) ( f ). Cells were irradiated with UV-C (purple) at 10 J/m 2 (a) or 20 J/m 2 (b, e, f) or left untreated (gray). Red fluorescence indicates PLA or immunostaining signals; nuclei were counterstained with DAPI (blue). In (d) and (e), green fluorescence marks R-loops labeled by the mRNH probe. Horizontal black bars indicate the median of each group. Asterisks indicate significant differences relative to untreated cells or between genotypes (* p < 0.05, *** p < 0.001). White scale bars, 10 μm. ( g ) Schematic model of the proposed DGCR8-mediated mechanism of R-loop regulation.

Journal: Scientific Reports

Article Title: DGCR8 regulates multiple processes of transcription coupled nucleotide excision repair

doi: 10.1038/s41598-026-38338-5

Figure Lengend Snippet: DGCR8-pS153 contributes to R-loop regulation. ( a ) R-loop detection by S9.6 immunostaining in Dgcr8 −/− MEFs transduced with wild-type human DGCR8, the S153A mutant, or an empty vector. Note that the vertical axis scale differs due to microscope camera settings (see Methods). White scale bars, 10 μm. ( b ) S9.6 immunostaining in wild-type and S153A U2-OS cells. ( c ) Schematic of the R-loop probe: a catalytically inactive RNase H1 mutant (D210N) fused to EGFP (mRNH) was used to visualize R-loops in live or fixed cells. ( d ) Colocalization of R-loops with nucleoli in non-irradiated U2-OS cells, with nucleoli labeled using Nucleolus Bright Red (Dojin). (e, f) PLA analyses of interactions between DGCR8 and R-loops ( e ) and between R-loops and UV-induced cyclobutane pyrimidine dimers (CPDs) ( f ). Cells were irradiated with UV-C (purple) at 10 J/m 2 (a) or 20 J/m 2 (b, e, f) or left untreated (gray). Red fluorescence indicates PLA or immunostaining signals; nuclei were counterstained with DAPI (blue). In (d) and (e), green fluorescence marks R-loops labeled by the mRNH probe. Horizontal black bars indicate the median of each group. Asterisks indicate significant differences relative to untreated cells or between genotypes (* p < 0.05, *** p < 0.001). White scale bars, 10 μm. ( g ) Schematic model of the proposed DGCR8-mediated mechanism of R-loop regulation.

Article Snippet: Dgcr8 -knockout MEFs were purchased from Novus Biologicals and cultured according to the manufacturer’s instructions.

Techniques: Immunostaining, Transduction, Mutagenesis, Plasmid Preparation, Microscopy, Irradiation, Labeling, Fluorescence